Literature DB >> 21965556

Proficiency testing/external quality assessment: current challenges and future directions.

W Greg Miller1, Graham R D Jones, Gary L Horowitz, Cas Weykamp.   

Abstract

BACKGROUND: Proficiency testing (PT), or external quality assessment (EQA), is intended to verify on a recurring basis that laboratory results conform to expectations for the quality required for patient care. CONTENT: Key factors for interpreting PT/EQA results are knowledge of the commutability of the samples used and the process used for target value assignment. A commutable PT/EQA sample demonstrates the same numeric relationship between different measurement procedures as that expected for patients' samples. Noncommutable PT/EQA samples frequently have a matrix-related bias of unknown magnitude that limits interpretation of results. PT/EQA results for commutable samples can be used to assess accuracy against a reference measurement procedure or a designated comparison method. In addition, the agreement of the results between different measurement procedures for commutable samples reflects that which would be seen for patients' samples. PT/EQA results for noncommutable samples must be compared to a peer group mean/median of results from participants who use measurement procedures that are expected to have the same or very similar matrix-related bias. Peer group evaluation is used to asses whether a laboratory is using a measurement procedure in conformance to the manufacturer's specifications and/or in conformance to other laboratories using the same technology. A noncommutable PT/EQA sample does not give meaningful information about the relationship of results for patients' samples between different measurement procedures.
SUMMARY: PT/EQA provides substantial value to the practice of laboratory medicine by assessing the performance of individual laboratories and, when commutable samples are used, the status of standardization or harmonization among different measurement procedures.

Entities:  

Mesh:

Year:  2011        PMID: 21965556     DOI: 10.1373/clinchem.2011.168641

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  44 in total

1.  Measurements for 8 common analytes in native sera identify inadequate standardization among 6 routine laboratory assays.

Authors:  Hedwig C M Stepman; Ulla Tiikkainen; Dietmar Stöckl; Hubert W Vesper; Selvin H Edwards; Harri Laitinen; Jonna Pelanti; Linda M Thienpont
Journal:  Clin Chem       Date:  2014-03-31       Impact factor: 8.327

2.  RCPAQAP First Combined Measurement and Reference Interval Survey.

Authors:  Graham Rd Jones; Sabrina DA Koetsier
Journal:  Clin Biochem Rev       Date:  2014-11

3.  Category 1 external quality assessment program for serum creatinine.

Authors:  Elisabet González-Lao; Jorge Díaz-Garzón; Zoraida Corte; Carmen Ricós; Carmen Perich; Virtudes Álvarez; Margarita Simón; Joana Minchinela; José Vicente García-Lario; Beatriz Boned; Carmen Biosca; Fernando Cava; Pilar Fernández-Fernández; Pilar Fernández-Calle
Journal:  Ann Transl Med       Date:  2017-03

4.  'Allowable Limits of Performance' for External Quality Assurance Programs - an Approach to Application of the Stockholm Criteria by the RCPA Quality Assurance Programs.

Authors:  Graham Rd Jones; Kenneth Sikaris; Janice Gill
Journal:  Clin Biochem Rev       Date:  2012-11

Review 5.  Evaluation of Performance of Laboratories and Manufacturers Within the Framework of the IFCC model for Quality Targets of HbA1c.

Authors:  Cas Weykamp; Carla Siebelder
Journal:  J Diabetes Sci Technol       Date:  2017-11-17

6.  A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience.

Authors:  Amélie Gaignaux; Garry Ashton; Domenico Coppola; Yvonne De Souza; Annemieke De Wilde; James Eliason; William Grizzle; Fiorella Guadagni; Elaine Gunter; Iren Koppandi; Katheryn Shea; Tim Shi; Julie A Stein; Mark E Sobel; Gunnel Tybring; Gert Van den Eynden; Fay Betsou
Journal:  Biopreserv Biobank       Date:  2016-05-19       Impact factor: 2.300

7.  Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratories.

Authors:  Robin DiFrancesco; Susan L Rosenkranz; Charlene R Taylor; Poonam G Pande; Suzanne M Siminski; Richard W Jenny; Gene D Morse
Journal:  Ther Drug Monit       Date:  2013-10       Impact factor: 3.681

8.  Sources of Variability and Accuracy of Performance Assessment in the Clinical Pharmacology Quality Assurance Proficiency Testing Program for Antiretrovirals.

Authors:  Richard W Browne; Susan L Rosenkranz; Yan Wang; Charlene R Taylor; Robin DiFrancesco; Gene D Morse
Journal:  Ther Drug Monit       Date:  2019-08       Impact factor: 3.681

9.  Standardizing vitamin D assays: the way forward.

Authors:  Neil Binkley; Christopher T Sempos
Journal:  J Bone Miner Res       Date:  2014-08       Impact factor: 6.741

10.  Quality specifications and their daily application to evaluate the accuracy of reference measurements for serum concentrations of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2.

Authors:  Ekaterina M Mineva; Maya R Sternberg; Christine M Pfeiffer; Shahzad S Momin; Khin L Maw; Rosemary L Schleicher
Journal:  Clin Chim Acta       Date:  2018-10-04       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.